Dow Jones

44,722.06

-0.31%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Day One Biopharmaceuticals Inc (DAWN)
Day One Biopharmaceuticals Inc (DAWN) Noticias

DAWN

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DAWN

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
20/11/2024	15:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
19/11/2024	15:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
18/11/2024	15:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
30/10/2024	15:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
28/08/2024	15:07	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
05/08/2024	16:05	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
04/01/2024	15:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
30/10/2023	09:54	Dow Jones News	Day One Biopharmaceuticals Shares Rally on FDA Priority Review	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
30/10/2023	07:58	Dow Jones News	Day One Gets FDA Priority Review of Tovorafenib in Pediatric Brain Tumor	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
20/10/2023	15:01	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
26/06/2023	18:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
23/06/2023	15:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
12/06/2023	15:13	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
08/06/2023	06:00	PR Newswire (US)	KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
07/06/2023	15:58	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
05/06/2023	15:50	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
01/05/2023	08:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
28/04/2023	15:12	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
28/04/2023	15:05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
14/02/2023	15:38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
13/02/2023	17:21	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
09/01/2023	12:16	Dow Jones News	Day One Biopharma Shares Rise 13% After Positive Topline Results for Tovorafenib	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
10/11/2022	06:15	TipRanks	J.P. Morgan Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
08/11/2022	07:55	TipRanks	JonesTrading Reaffirms Their Buy Rating on Day One Biopharmaceuticals (DAWN)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
31/10/2022	15:08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
14/09/2022	10:05	TipRanks	JonesTrading Remains a Buy on Day One Biopharmaceuticals (DAWN)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
12/09/2022	10:14	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
05/09/2022	16:15	TipRanks	Day One Biopharmaceuticals (DAWN) Receives a Buy from JonesTrading	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
23/06/2022	18:26	TipRanks	Insiders Go All-In on These 2 ‘Strong Buy’ Stocks	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
23/06/2022	07:54	TipRanks	This Top Insider Just Increased Its Appetite for DAWN Stock	NASDAQ:DAWN	Day One Biopharmaceuticals Inc